Corcept Therapeutics (CORT) News Today $69.00 +1.83 (+2.72%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$68.94 -0.06 (-0.09%) As of 08/1/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Corcept Therapeutics Up Today?Toggle Visibility of Why Is Corcept Therapeutics Up Today?Corcept Therapeutics Incorporated (NASDAQ: CORT) has seen its shares move on a mix of earnings results, guidance updates and analyst revisions. Key developments include: Positive Sentiment: Q2 EPS of $0.29 beat the Zacks consensus of $0.23, demonstrating continued earnings strength. Corcept Therapeutics (CORT) Tops Q2 Earnings Estimates Positive Sentiment: Zacks Research lifted its FY2026 EPS estimate to $1.68 from $1.65 and boosted Q4 2026 EPS to $0.55 (from $0.53), signaling growing confidence in Corcept’s longer-term profitability. Q4 EPS Forecast for Corcept Therapeutics Lifted by Analyst Positive Sentiment: H.C. Wainwright reiterated its Buy rating with a $145 price target, citing strategic growth initiatives and promising upcoming product launches. Corcept Therapeutics: Buy Rating Backed by Strategic Growth Initiatives and Promising Product Launches Neutral Sentiment: Management discussion released in the Q2 2025 earnings call transcript, detailing progress in the hypercortisolism franchise and pipeline updates. CORT Q2 2025 Earnings Call Transcript Negative Sentiment: Revenue of $194.43 million fell short of the $199.40 million estimate, and full-year revenue guidance was trimmed to $850–900 million (below the $899 million consensus). CORT's Q2 Earnings Top Mark, Revenues Lag, '25 View Cut Negative Sentiment: Canaccord Genuity lowered its price target from $142 to $137, though it maintained a Buy rating, reflecting tempered upside expectations. Benzinga Negative Sentiment: Piper Sandler cut its target from $131 to $121 while keeping an Overweight rating, indicating cautious sentiment on near-term growth. Benzinga Posted 11h agoAI Generated. May Contain Errors. CORT Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Corcept Therapeutics Incorporated (NASDAQ:CORT) Shares Bought by Jupiter Asset Management Ltd.1 hour ago | marketbeat.comCorcept Therapeutics Incorporated (CORT) Q2 2025 Earnings Call TranscriptAugust 1 at 3:11 PM | seekingalpha.comCorcept Therapeutics (CORT) Target Price Revised by Piper Sandler AnalystAugust 1 at 10:42 AM | gurufocus.comCorcept Therapeutics (CORT) Price Target Lowered, Buy Rating MaintainedAugust 1 at 9:52 AM | gurufocus.comPiper Sandler Lowers Price Target for Corcept Therapeutics (CORT) | CORT Stock NewsAugust 1 at 9:01 AM | gurufocus.comQ4 EPS Forecast for Corcept Therapeutics Lifted by AnalystAugust 1 at 7:25 AM | marketbeat.comCorcept Therapeutics: Buy Rating Backed by Strategic Growth Initiatives and Promising Product LaunchesAugust 1 at 6:34 AM | tipranks.comZacks Research Analysts Boost Earnings Estimates for CORTAugust 1 at 3:17 AM | americanbankingnews.comQ2 2025 Corcept Therapeutics Inc Earnings Call TranscriptJuly 31 at 12:41 AM | gurufocus.comCorcept Therapeutics falls as revenue guidance disappoints investorsJuly 31 at 6:07 PM | za.investing.comCorcept (NASDAQ:CORT) Misses Q2 Sales TargetsJuly 31 at 6:07 PM | finance.yahoo.comCorcept Therapeutics Reports Q2 2025 Financial ResultsJuly 31 at 5:02 PM | tipranks.comCorcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate UpdateJuly 31 at 4:05 PM | businesswire.comBaader Bank Aktiengesellschaft Acquires Shares of 5,464 Corcept Therapeutics Incorporated (NASDAQ:CORT)July 31 at 3:22 AM | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New $2.12 Million Investment in Corcept Therapeutics Incorporated (NASDAQ:CORT)July 31 at 3:22 AM | marketbeat.comCorcept Therapeutics Advances Long-Term Safety Study of Relacorilant for Cushing SyndromeJuly 30 at 12:25 PM | tipranks.comWhat To Expect From Corcept’s (CORT) Q2 EarningsJuly 30 at 8:46 AM | msn.comBayforest Capital Ltd Raises Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)July 30 at 3:19 AM | marketbeat.comGSA Capital Partners LLP Has $2.48 Million Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)July 29, 2025 | marketbeat.comSheaff Brock Investment Advisors LLC Invests $951,000 in Corcept Therapeutics Incorporated (NASDAQ:CORT)July 29, 2025 | marketbeat.comCorcept Therapeutics Advances Pipeline Fueling Growth With Controlled RiskJuly 28, 2025 | finance.yahoo.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Purchased by Assetmark Inc.July 28, 2025 | marketbeat.comH.C. Wainwright Remains Bullish on Corcept Therapeutics Incorporated (CORT)July 28, 2025 | msn.comCorcept Therapeutics Advances Pipeline Fueling Growth With Controlled RiskJuly 27, 2025 | msn.comCorcept Therapeutics (CORT) Projected to Post Quarterly Earnings on ThursdayJuly 27, 2025 | marketbeat.comNeo Ivy Capital Management Buys Shares of 6,972 Corcept Therapeutics Incorporated (NASDAQ:CORT)July 27, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Stock Position Lifted by Westover Capital Advisors LLCJuly 26, 2025 | marketbeat.comCorcept (CORT) Advances Ovarian Cancer Therapy with FDA Filing for RelacorilantJuly 25, 2025 | finance.yahoo.com9,931 Shares in Corcept Therapeutics Incorporated (NASDAQ:CORT) Acquired by Brookwood Investment Group LLCJuly 25, 2025 | marketbeat.comRoyce & Associates LP Lowers Position in Corcept Therapeutics Incorporated (NASDAQ:CORT)July 25, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Receives $138.25 Average Target Price from BrokeragesJuly 25, 2025 | americanbankingnews.comY Intercept Hong Kong Ltd Has $1.03 Million Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)July 25, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Bought by Victory Capital Management Inc.July 25, 2025 | marketbeat.comCorcept Therapeutics Inc (CORT) to Announce Q2 Financial Results and Corporate Update | CORT ...July 24, 2025 | gurufocus.comCorcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference CallJuly 24, 2025 | businesswire.comBurney Co. Sells 207,424 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)July 23, 2025 | marketbeat.comLegato Capital Management LLC Has $3.20 Million Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT)July 23, 2025 | marketbeat.comSean Maduck Sells 4,315 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) StockJuly 23, 2025 | americanbankingnews.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Shares Bought by Los Angeles Capital Management LLCJuly 22, 2025 | marketbeat.comInsider Selling: Corcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells 200 Shares of StockJuly 22, 2025 | insidertrades.comNew York State Common Retirement Fund Sells 3,862 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT)July 22, 2025 | marketbeat.comInsider Sell: William Guyer Sells Shares of Corcept Therapeutics Inc (CORT)July 22, 2025 | gurufocus.comInsider Selling: Corcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells 200 Shares of StockJuly 21, 2025 | marketbeat.comInsider Selling: Corcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells 473 Shares of StockJuly 21, 2025 | marketbeat.comWilliam Guyer Sells 500 Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) StockJuly 21, 2025 | marketbeat.comInsider Selling: Corcept Therapeutics Incorporated (NASDAQ:CORT) CEO Sells 615 Shares of StockJuly 21, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells $284,881.96 in StockJuly 21, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells $317,066.20 in StockJuly 21, 2025 | marketbeat.comInsider Selling: Corcept Therapeutics Incorporated (NASDAQ:CORT) Insider Sells 4,379 Shares of StockJuly 21, 2025 | marketbeat.comCorcept Therapeutics Incorporated (NASDAQ:CORT) Receives Average Recommendation of "Buy" from BrokeragesJuly 20, 2025 | marketbeat.com Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address CORT Media Mentions By Week CORT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CORT News Sentiment▼0.900.63▲Average Medical News Sentiment CORT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CORT Articles This Week▼3311▲CORT Articles Average Week Get Corcept Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CORT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Annovis Bio News Today Royalty Pharma News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Nektar Therapeutics News Today Omeros News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CORT) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Corcept Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Corcept Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CORT Stock Alerts